Literature DB >> 10669650

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation.

C Dachet1, O Poirier, F Cambien, J Chapman, M Rouis.   

Abstract

A new polymorphism located at position -629 (CETP/-629A/C) in the promoter of the cholesteryl ester transfer protein (CETP) gene is described. The -629A allele was associated with lower CETP mass (P<0. 0001) and higher high density lipoprotein cholesterol (P<0.001) than the C allele in a sample of 536 control subjects from the ECTIM study. Transfection studies in HepG2 cells with a luciferase expression vector incorporating a 777-bp fragment of the CETP promoter and containing either A or C at position -629 showed significantly lower luciferase activity with the promoter fragment of the A allele (-25%, P<0.05). By gel-shift assay, DNA-protein interactions were evaluated in nuclear extracts of HepG2 cells with the use of 2 probes (A or C probe) composed of 20 bp of the promoter sequence surrounding the polymorphic site. Two specific complexes of distinct migration rate were identified with the A and the C probe. Competition with an excess of oligonucleotide containing the Sp1 consensus binding site showed that a protein(s) of the Sp transcription factor family was implicated in complex formation with the A probe but not with the C probe. Incubation with specific antibodies indicated that Sp1 and Sp3 bound specifically to the A probe. We introduced mutations in the -629-Sp1 binding site to test its functionality and to define the characteristics of transcription factor binding. We showed, by gel-shift assay, that no nuclear proteins bound to the mutated sequence. Transient transfection of HepG2 cells revealed that the expression of the mutated fragment was significantly increased compared with that of the A promoter fragment (25%, P<0.05). The mutated fragment displayed the same activity as that of the C promoter. These results indicate that Sp1 and/or Sp3 repress CETP promoter activity, whereas nuclear factors binding the C allele are without effect on promoter expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669650     DOI: 10.1161/01.atv.20.2.507

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  39 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease.

Authors:  Lei Yu; Joshua M Shulman; Lori Chibnik; Sue Leurgans; Julie A Schneider; Philip L De Jager; David A Bennett
Journal:  Aging Cell       Date:  2011-12-29       Impact factor: 9.304

3.  Cholesteryl ester transfer protein (CETP) -629C/A polymorphism and it's effects on the serum lipid levels in metabolic syndrome patients.

Authors:  M Akbarzadeh; T Hassanzadeh; M Saidijam; R Esmaeili; Sh Borzouei; M Hajilooi; H Mahjub; M Paoli
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

4.  Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levels.

Authors:  Dilek Pirim; Xingbin Wang; Vipavee Niemsiri; Zaheda H Radwan; Clareann H Bunker; John E Hokanson; Richard F Hamman; M Michael Barmada; F Yesim Demirci; M Ilyas Kamboh
Journal:  Metabolism       Date:  2015-09-30       Impact factor: 8.694

Review 5.  Common variation in genes involved in HDL metabolism influences coronary heart disease risk at the population level.

Authors:  Margaret E Brousseau
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

Review 6.  Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation.

Authors:  François Cambien
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

7.  Association of Cholesteryl Ester Transfer Protein (CETP) Gene -629C/A Polymorphism with Angiographically Proven Atherosclerosis.

Authors:  Anita Devi; Ritu Singh; Rajni Dawar; Sanjay Tyagi
Journal:  Indian J Clin Biochem       Date:  2016-06-11

Review 8.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

9.  Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.

Authors:  H Qureischie; R Heun; J Popp; F Jessen; W Maier; S Schmitz; F Hentschel; P Kelemen; H Kölsch
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

10.  Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease.

Authors:  Pamela A McCaskie; John P Beilby; Caroline M L Chapman; Joseph Hung; Brendan M McQuillan; Peter L Thompson; Lyle J Palmer
Journal:  Hum Genet       Date:  2007-02-08       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.